ConductScience.org, home

Paper38809367

Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy.

Tanaka Y and 7 others. Infect Dis Ther, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy. Papers, record 38809367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38809367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy.
PubMed
Journal
Infect Dis Ther
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.87, provisional
iCite
Revised in PubMed
2024-08-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tanaka YYasuhito
2Nakamoto DDaisuke
3Piao YYi
4Mizutani HHajime
5Wakabayashi RRyozo
6Saito YYoshiyuki
7Kwon KMKyung Min
8Dickinson HHarriet

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120546439Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.J Gastroenterol Hepatol2010https://conductscience.org/library/papers/20546439PubMed
220525968Managing HBV in patients with impaired immunity.Gut2010https://conductscience.org/library/papers/20525968PubMed
31983820Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.Gastroenterology1991https://conductscience.org/library/papers/1983820PubMed
411055239Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.J Med Virol2000https://conductscience.org/library/papers/11055239PubMed
517894766Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.Intern Med J2007https://conductscience.org/library/papers/17894766PubMed
620556450Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.Clin Rheumatol2010https://conductscience.org/library/papers/20556450PubMed
720668905Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.Mod Rheumatol2011https://conductscience.org/library/papers/20668905PubMed
836840482Risk of hepatitis B reactivation in HBsAg-/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta-analysis.Immun Inflamm Dis2023https://conductscience.org/library/papers/36840482PubMed
928706414Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.World J Gastroenterol2017https://conductscience.org/library/papers/28706414PubMed
1037736699Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.Infect Dis Poverty2023https://conductscience.org/library/papers/37736699PubMed
1135635496Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection.Hepatol Res2022https://conductscience.org/library/papers/35635496PubMed
1218643758Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan.Clin Infect Dis2008https://conductscience.org/library/papers/18643758PubMed
1335076895Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.Hepatol Int2022https://conductscience.org/library/papers/35076895PubMed
1433828065Hepatitis B Reactivation: A Review of Clinical Guidelines.J Clin Gastroenterol2021https://conductscience.org/library/papers/33828065PubMed
1525935551Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.Clin Infect Dis2015https://conductscience.org/library/papers/25935551PubMed
1627260010Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.Int J Clin Oncol2016https://conductscience.org/library/papers/27260010PubMed
1724898712Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.Tohoku J Exp Med2014https://conductscience.org/library/papers/24898712PubMed
1833977008Data resource profile: JMDC claims database sourced from health insurance societies.J Gen Fam Med2021https://conductscience.org/library/papers/33977008PubMed
1929030713Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.J Gastroenterol2018https://conductscience.org/library/papers/29030713PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
41673342Prevention of hepatitis B virus reactivation according to hepatitis B surface antigen status in patients receiving systemic chemotherapy in Japan using an electronic medical record database.Int J Clin Oncol2026https://conductscience.org/library/papers/41673342

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38809367

GET https://conductscience.org/api/papers/v1/38809367/authors